Service-based survey of dystonia in Munich

被引:55
作者
Konkiewitz, EC
Trender-Gerhard, I
Kamm, C
Warner, T
Ben-Shlomo, Y
Gasser, T
Conrad, B
Ceballos-Baumann, AO
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany
关键词
dystonia; prevalence; botulinum toxin; epidemiology; Munich;
D O I
10.1159/000059525
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We performed a service-based epidemiological study of dystonia in Munich, Germany. Due to favourable referral and treatment patterns in the Munich area, we could provide confident data from dystonia patients seeking botulinum toxin treatment. A total of 230 patients were ascertained, of whom 188 had primary dystonia. Point prevalence ratios were estimated to be 10.1 (95% confidence interval 8.4-11.9) per 100,000 for focal and 0.3 (0.0-0.6) for generalised primary dystonia. The most common focal primary dystonias were cervical dystonia with 5.4 (4.2-6.7) and essential blepharospasm with 3.1 (2.1-4.1) per 100,000 followed by laryngeal dystonia (spasmodic dysphonia) with 1.0 (0.4-1.5) per 100,000. Copyright (C) 2002 S. Karger AG, Base.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 17 条
[1]   The current status of tardive dystonia [J].
Adityanjee ;
Aderibigbe, YA ;
Jampala, VC ;
Mathews, T .
BIOLOGICAL PSYCHIATRY, 1999, 45 (06) :715-730
[2]  
BANDMANN O, 1998, DYSTONIA 3, V78, P283
[3]  
BUTLER AG, 1998, DYSTONIA 3, V78, P349
[4]   EPIDEMIOLOGY AND OUTCOME OF CERVICAL DYSTONIA (SPASMODIC TORTICOLLIS) IN ROCHESTER, MINNESOTA [J].
CLAYPOOL, DW ;
DUANE, DD ;
ILSTRUP, DM ;
MELTON, LJ .
MOVEMENT DISORDERS, 1995, 10 (05) :608-614
[5]   Costs of treating dystonias and hemifacial spasm with botulinum toxin A [J].
Dodel, RC ;
Kirchner, A ;
KoehneVolland, R ;
Kunig, G ;
CeballosBaumann, A ;
Naumann, M ;
Brashear, A ;
Richter, HP ;
Szucs, TD ;
Oertel, WH .
PHARMACOECONOMICS, 1997, 12 (06) :695-706
[6]  
DUFFEY PO, 1998, DYSTONIA 3, V78, P121
[7]  
ERJANTI HM, 1996, MOV DISORD S1, V11, P215
[8]  
*ESDE COLL GROUP, 1999, NEUROLOGY, V10, P1871
[9]  
Fahn S, 1998, Adv Neurol, V78, P1
[10]  
Fahn S, 1988, Adv Neurol, V50, P1